Identification of Ligand Binding Hot Spots of the Histamine H1 Receptor following Structure-Based Fragment Optimization

被引:23
作者
Kuhne, Sebastiaan [1 ]
Kooistra, Albert J. [1 ]
Bosma, Reggie [1 ]
Bortolato, Andrea [2 ]
Wijtmans, Maikel [1 ]
Vischer, Henry F. [1 ]
Mason, Jonathan S. [2 ]
de Graaf, Chris [1 ]
de Esch, Iwan J. P. [1 ]
Leurs, Rob [1 ]
机构
[1] Vrije Univ Amsterdam, AIMMS, Div Med Chem, Fac Sci, De Boelelaan 1108, NL-1081 HZ Amsterdam, Netherlands
[2] Heptares Therapeut Ltd, BioPk,Broadwater Rd, Welwyn Garden City AL7 3AX, Herts, England
关键词
MUTATIONAL ANALYSIS; EFFICIENCY; SITE; AGONIST; DESIGN; DRUGGABILITY; AFFINITY; DOCKING; DOMAIN; POCKET;
D O I
10.1021/acs.jmedchem.6b00981
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Developments in G protein-coupled receptor (GPCR) structural biology provide insights into GPCR-ligand binding.,Compound 1 (4-(2-benzylphenoxy)piperidine) with high ligand efficiency for the histamine H-1 receptor (H1R) was used to design derivatives to investigate the roles of (i) the amine-binding region, (ii) the upper and lower aromatic region, and (iii) binding site solvation. SAR analysis showed that the amine-binding region serves as the primary binding hot spot, preferably binding small tertiary amines. In silico prediction of water network energetics and mutagenesis studies indicated that the displacement of a water molecule from the amine-binding region is most likely responsible for the increased affinity,of the N-methylated analog of 1. Deconstruction of 1 showed that the lower aromatic region serves as a secondary binding hot spot. This study,demonstrates that an X-ray structure in combination with tool compounds, assessment of water energetics, and mutagenesis studies enables SAR exploration to map GPCR-ligand binding hot spots.
引用
收藏
页码:9047 / 9061
页数:15
相关论文
共 50 条
[1]   Role of the active-site solvent in the thermodynamics of factor Xa ligand binding [J].
Abel, Robert ;
Young, Tom ;
Farid, Ramy ;
Berne, Bruce J. ;
Friesner, Richard A. .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2008, 130 (09) :2817-2831
[2]   Structure-based drug design of chromone antagonists of the adenosine A2A receptor [J].
Andrews, Stephen P. ;
Mason, Jonathan S. ;
Hurrell, Edward ;
Congreve, Miles .
MEDCHEMCOMM, 2014, 5 (05) :571-575
[3]  
[Anonymous], 2010, Drug Discov Today Technol, V7, pe147, DOI 10.1016/j.ddtec.2010.11.003
[4]  
[Anonymous], 2013, WATERMAP
[5]  
[Anonymous], 2008, CALC VERS 5 1 4
[6]  
[Anonymous], 2011, COR VERS 3 49
[7]   Domain swapping in the human histamine H1 receptor [J].
Bakker, RA ;
Dees, G ;
Carrillo, JJ ;
Booth, RG ;
López-Gimenez, JF ;
Milligan, G ;
Strange, PG ;
Leurs, R .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 311 (01) :131-138
[8]   Histamine H1-receptor activation of nuclear factor-κB:: Roles for Gβγ- and Gαq/11-subunits in constitutive and agonist-mediated signaling [J].
Bakker, RA ;
Schoonus, SBJ ;
Smit, MJ ;
Timmerman, H ;
Leurs, R .
MOLECULAR PHARMACOLOGY, 2001, 60 (05) :1133-1142
[9]  
Ballesteros J. A., 1995, Neuroscience Methods, P366, DOI [DOI 10.1016/S1043-9471, DOI 10.1016/S1043-9471(05)80049-7]
[10]   The Methylation Effect in Medicinal Chemistry [J].
Barreiro, Eliezer J. ;
Kuemmerle, Arthur E. ;
Fraga, Carlos A. M. .
CHEMICAL REVIEWS, 2011, 111 (09) :5215-5246